Systemic Lupus Erythematosus

Rheumatic Disease Clinics of North America

Volumn 33, Issue 3, 2007, Pages 471-498

  Benseler, Susanne M ^a   Silverman, Earl D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; STEROID; TACROLIMUS;

ARTHRITIS; AUTOIMMUNE DISEASE; CARDIOMYOPATHY; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; COGNITIVE DEFECT; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; DRUG MEGADOSE; DRUG PULSE THERAPY; FACE RASH; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPATHOLOGY; INCIDENCE; INFLAMMATION; KIDNEY DISEASE; LABORATORY DIAGNOSIS; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MOTOR DYSFUNCTION; MOUTH ULCER; MUSCULOSKELETAL DISEASE; MYOKYMIA; NEUROLOGIC DISEASE; PERIPHERAL NERVOUS SYSTEM; PHOTOSENSITIVITY; PRIORITY JOURNAL; PSYCHOSIS; RETINA MACULOPATHY; REVIEW; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 35148862577     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.07.008     Document Type: Review

References (104)

1. Tan E.M., Fries J.F., Masi A.T., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
2. Hopkinson N.D., Doherty M., and Powell R.J. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 53 (1994) 675-680
3. Ghaussy N.O., Sibbitt W., Bankhurst A.D., et al. The effect of race on disease activity in systemic lupus erythematosus. J Rheumatol 31 (2004) 915-919
4. Cooper G.S., Parks C.G., Treadwell E.L., et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 11 (2002) 161-167
5. Lopez P., Mozo L., Gutierrez C., et al. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 12 (2003) 860-865
6. Alamanos Y., Voulgari P.V., Siozos C., et al. Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001. J Rheumatol 30 (2003) 731-735
7. Nossent H.C. Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol 28 (2001) 539-546
8. McCarty D.J., Manzi S., Medsger T.A., et al. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 38 (1995) 1260-1270
9. Siegel M., and Lee S.L. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 3 (1973) 1-54
10. Mok C.C., and Lau C.S. Lupus in Hong Kong Chinese. Lupus 12 (2003) 717-722
11. Vilar M.J., and Sato E.I. Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). Lupus 11 (2002) 528-532
12. Peschken C.A., and Esdaile J.M. Systemic lupus erythematosus in North American Indians: a population based study. J Rheumatol 27 (2000) 1884-1891
13. Lo J.T., Tsai M.J., Wang L.H., et al. Sex differences in pediatric systemic lupus erythematosus: a retrospective analysis of 135 cases. J Microbiol Immunol Infect 32 (1999) 173-178
14. Bogdanovic R., Nikolic V., Pasic S., et al. Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol 19 (2004) 36-44
15. Mok C.C., Lee K.W., Ho C.T., et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford) 39 (2000) 399-406
16. Balkaran B.N., Roberts L.A., and Ramcharan J. Systemic lupus erythematosus in Trinidadian children. Ann Trop Paediatr 24 (2004) 241-244
17. Cervera R., Khamashta M.A., Font J., et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82 (2003) 299-308
18. Bellomio V., Spindler A., Lucero E., et al. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. Lupus 9 (2000) 377-381
19. Caeiro F., Michielson F.M., Bernstein R., et al. Systemic lupus erythematosus in childhood. Ann Rheum Dis 40 (1981) 325-331
20. Miettunen P.M., Ortiz-Alvarez O., Petty R.E., et al. Gender and ethnic origin have no effect on long-term outcome of childhood-onset systemic lupus erythematosus. J Rheumatol 31 (2004) 1650-1654
21. Wang L.C., Yang Y.H., Lu M.Y., et al. Retrospective analysis of mortality and morbidity of pediatric systemic lupus erythematosus in the past two decades. J Microbiol Immunol Infect 36 (2003) 203-208
22. Vyas S., Hidalgo G., Baqi N., et al. Outcome in African-American children of neuropsychiatric lupus and lupus nephritis. Pediatr Nephrol 17 (2002) 45-49
23. Segasothy M., and Phillips P.A. Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study. Lupus 10 (2001) 439-444
24. Alsaeid K., Kamal H., Haider M.Z., et al. Systemic lupus erythematosus in Kuwaiti children: organ system involvement and serological findings. Lupus 13 (2004) 613-617
25. Ward M.M. Education level and mortality in systemic lupus erythematosus (SLE): evidence of underascertainment of deaths due to SLE in ethnic minorities with low education levels. Arthritis Rheum 51 (2004) 616-624
26. Ali U.S., Dalvi R.B., Merchant R.H., et al. Systemic lupus erythematosus in Indian children. Indian Pediatr 26 (1989) 868-873
27. Chen Y.S., Yang Y.H., Lin Y.T., et al. Risk of infection in hospitalised children with systemic lupus erythematosus: a 10-year follow-up. Clin Rheumatol 23 (2004) 235-238
28. Sibbitt W.L., Brandt J.R., Johnson C.R., et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 29 (2002) 1536-1542
29. Huong D.L., Papo T., Beaufils H., et al. A study of 180 patients from a single center. Medicine (Baltimore) 78 (1999) 148-166
30. Saurit V., Campana R., Ruiz Lascano A., et al. [Mucocutaneous lesions in patients with systemic lupus erythematosus]. Medicina (B Aires) 63 (2003) 283-287 [in Portuguese]
31. Vuilleumier C., Sauvain M.J., Aebi C., et al. Systemic lupus erythematosus initially presenting as idiopathic juvenile arthritis with positive antinuclear antibodies. Acta Paediatr 92 (2003) 512-513
32. Saulsbury F.T., Kesler R.W., Kennaugh J.M., et al. Overlap syndrome of juvenile rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 9 (1982) 610-612
33. Citera G., Espada G., and Maldonado Cocco J.A. Sequential development of 2 connective tissue diseases in juvenile patients. J Rheumatol 20 (1993) 2149-2152
34. Noguera A., Ros J.B., Pavia C., et al. Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children. J Pediatr Endocrinol Metab 16 (2003) 529-536
35. Cimaz R. Osteoporosis in childhood rheumatic diseases: prevention and therapy. Best Pract Res Clin Rheumatol 16 (2002) 397-409 [Abstract Abstract + References Full-Text PDF (183 KB)]
36. Mavrikakis I., Sfikakis P.P., Mavrikakis E., et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology 110 (2003) 1321-1326 [Abstract Full Text Full-Text PDF (371 KB)]
37. Marmor M.F. New American Academy of ophthalmology recommendations on screening for hydroxychloroquine retinopathy. Arthritis Rheum 48 (2003) 1764
38. Berkel A.I., Birben E., Oner C., et al. Molecular, genetic and epidemiologic studies on selective complete C1q deficiency in Turkey. Immunobiology 201 (2000) 347-355
39. Siamopoulou-Mavridou A., Mavridis A.K., Dimou G., et al. Clinical and serological spectrum of systemic lupus erythematosus in Greek children. Clin Rheumatol 10 (1991) 264-268
40. Steinlin M.I., Blaser S.I., Gilday D.L., et al. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol 13 (1995) 191-197
41. Platt J.L., Burke B.A., Fish A.J., et al. Systemic lupus erythematosus in the first two decades of life. [Abstract]. Am J Kidney Dis 2 (1982) 212-222
42. Yancey C.L., Doughty R.A., and Athreya B.H. Central nervous system involvement in childhood systemic lupus erythematosus. Arthritis Rheum 24 (1981) 1389-1395
43. Loh W.F., Hussain I.M., Soffiah A., et al. Neurological manifestations of children with systemic lupus erythematosus. Med J Malaysia 55 (2000) 459-463
44. The American College of Rheumatology. Nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42 (1999) 599-608
45. Ainiala H., Hietaharju A., Loukkola J., et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 45 (2001) 419-423
46. Steens S.C., Bosma G.P., ten Cate R., et al. A neuroimaging follow up study of a patient with juvenile central nervous system systemic lupus erythematosus. Ann Rheum Dis 62 (2003) 583-586
47. Mitsikostas D.D., Sfikakis P.P., and Goadsby P.J. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain 127 (2004) 1200-1209
48. Levy D.M., Massicotte M.P., Harvey E., et al. Thromboembolism in paediatric lupus patients. Lupus 12 (2003) 741-746
49. Karassa F.B., Magliano M., and Isenberg D.A. Suicide attempts in patients with systemic lupus erythematosus. Ann Rheum Dis 62 (2003) 58-60
50. Russo R., Gilday D., Laxer R.M., et al. Single photon emission computed tomography scanning in childhood systemic lupus erythematosus. J Rheumatol 25 (1998) 576-582
51. Ingram D.G., and Hagemann T.M. Promethazine treatment of steroid-induced psychosis in a child. Ann Pharmacother 37 (2003) 1036-1039
52. Klein-Gitelman M.S., and Pachman L.M. Intravenous corticosteroids: adverse reactions are more variable than expected in children. J Rheumatol 25 (1998) 1995-2002
53. Sanna G., Bertolaccini M.L., Cuadrado M.J., et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30 (2003) 985-992
54. Liem M.D., Gzesh D.J., and Flanders A.E. MRI and angiographic diagnosis of lupus cerebral vasculitis. Neuroradiology 38 (1996) 134-136
55. Tan E.K., Chan L.L., and Auchus A.P. Reversible parkinsonism in systemic lupus erythematosus. J Neurol Sci 193 (2001) 53-57
56. Bruyn G.W., and Padberg G. Chorea and systemic lupus erythematosus. A critical review. Eur Neurol 23 (1984) 435-448
57. Besbas N., Damarguc I., Ozen S., et al. Association of antiphospholipid antibodies with systemic lupus erythematosus in a child presenting with chorea: a case report. Eur J Pediatr 153 (1994) 891-893
58. Campello I., Almarcegui C., Velilla J., et al. [Peripheral neuropathy in systemic lupus erythematosus]. Rev Neurol 33 (2001) 27-30 [in Spanish]
59. Al-Mayouf S.M., and Al-Hemidan A.I. Ocular manifestations of systemic lupus erythematosus in children. Saudi Med J 24 (2003) 964-966
60. Genevay S., Hayem G., Hamza S., et al. A possible role of antiphospholipid syndrome. Lupus 11 (2002) 313-316
61. Blaustein D.A., and Blaustein S.A. Antinuclear antibody negative systemic lupus erythematosus presenting as bilateral facial paralysis. J Rheumatol 25 (1998) 798-800
62. Liao C.H., Yang Y.H., and Chiang B.L. Systemic lupus erythematosus with presentation as vertigo and vertical nystagmus: report of one case. Acta Paediatr Taiwan 44 (2003) 158-160
63. Olfat M.O., Al-Mayouf S.M., and Muzaffer M.A. Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus. Clin Rheumatol 23 (2004) 395-399
64. al-Mayouf S.M., and Bahabri S. Spinal cord involvement in pediatric systemic lupus erythematosus: case report and literature review. Clin Exp Rheumatol 17 (1999) 505-508
65. Maule S., Quadri R., Mirante D., et al. Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structures. Clin Exp Immunol 110 (1997) 423-427
66. Abbott N.J., Mendonca L.L., and Dolman D.E. The blood-brain barrier in systemic lupus erythematosus. Lupus 12 (2003) 908-915
67. Gilad R., Lampl Y., Eshel Y., et al. Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus. Br J Rheumatol 36 (1997) 190-193
68. Jara L.J., Irigoyen L., Ortiz M.J., et al. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol 17 (1998) 110-114
69. Ainiala H., Hietaharju A., Dastidar P., et al. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Arthritis Rheum 50 (2004) 858-865
70. Uziel Y., Laxer R.M., Blaser S., et al. Cerebral vein thrombosis in childhood systemic lupus erythematosus. J Pediatr 126 (1995) 722-727
71. Reiff A., Miller J., Shaham B., et al. Childhood central nervous system lupus; longitudinal assessment using single photon emission computed tomography. J Rheumatol 24 (1997) 2461-2465
72. Liu F.Y., Huang W.S., Kao C.H., et al. Usefulness of Tc-99m ECD brain SPECT to evaluate the effects of methylprednisolone pulse therapy in lupus erythematosus with brain involvement: a preliminary report. Rheumatol Int 23 (2003) 182-185
73. Barron K.S., Silverman E.D., Gonzales J., et al. Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum 36 (1993) 348-354
74. Chandrasekaran A.N., Rajendran C.P., Ramakrishnan S., et al. Childhood systemic lupus erythematosus in south India. Indian J Pediatr 61 (1994) 223-229
75. Hagelberg S., Lee Y., Bargman J., et al. Long-term followup of childhood lupus nephritis. J Rheumatol 29 (2002) 2635-2642
76. Gupta K.L. Lupus nephritis in children. Indian J Pediatr 66 (1999) 215-223
77. Sumboonnanonda A., Vongjirad A., Suntornpoch V., et al. Renal pathology and long-term outcome in childhood SLE. J Med Assoc Thai 81 (1998) 830-834
78. Weening J.J., D'Agati V.D., Schwartz M.M., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15 (2004) 241-250
79. Austin H.A., Muenz L.R., Joyce K.M., et al. Contribution of renal histologic data. Am J Med 75 (1983) 382-391
80. Schwartz M.M., Lan S.P., Bernstein J., et al. Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 21 (1993) 374-377
81. Appel G.B., Pirani C.L., and D'Agati V. Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 4 (1994) 1499-1515
82. Wu C.T., Fu L.S., Wen M.C., et al. Lupus vasculopathy combined with acute renal failure in lupus nephritis. Pediatr Nephrol 18 (2003) 1304-1307
83. Yee C.S., Gordon C., Dostal C., et al. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis. Ann Rheum Dis 63 (2004) 525-529
84. Chan T.M., Tse K.C., Tang C.S., et al. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 16 (2005) 1076-1084
85. Hu W., Liu Z., Chen H., et al. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. Chin Med J (Engl) 115 (2002) 705-709
86. Ginzler E.M., Dooley M.A., Aranow C., et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353 (2005) 2219-2228
87. Buratti S., Szer I.S., Spencer C.H., et al. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol 28 (2001) 2103-2108
88. Zimmerman S.A., and Ware R.E. Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 19 (1997) 297-303
89. Marks S.D., Patey S., Brogan P.A., et al. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus. Arthritis Rheum 52 (2005) 3168-3174
90. Berube C., Mitchell L., Silverman E., et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatr Res 44 (1998) 351-356
91. McClain M.T., Arbuckle M.R., Heinlen L.D., et al. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 50 (2004) 1226-1232
92. Eberhard A., Sparling C., Sudbury S., et al. Hypoprothrombinemia in childhood systemic lupus erythematosus. Semin Arthritis Rheum 24 (1994) 12-18
93. Chan Y.K., Li E.K., Tam L.S., et al. Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis. Scand J Rheumatol 32 (2003) 306-308
94. Guevara J.P., Clark B.J., and Athreya B.H. Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus. J Rheumatol 28 (2001) 854-859
95. Falaschi F., Ravelli A., Martignoni A., et al. Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 43 (2000) 1405-1409
96. Soep J.B., Mietus-Snyder M., Malloy M.J., et al. Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus. Arthritis Rheum 51 (2004) 451-457
97. Molina J.F., Brown R.F., Gedalia A., et al. Protein losing enteropathy as the initial manifestation of childhood systemic lupus erythematosus. J Rheumatol 23 (1996) 1269-1271
98. Duncan H.V., and Achara G. A rare initial manifestation of systemic lupus erythematosus-acute pancreatitis: case report and review of the literature. J Am Board Fam Pract 16 (2003) 334-338
99. Swol-Ben J., Bruns C.J., Muller-Ladner U., et al. Leukoencephalopathy and chronic pancreatitis as concomitant manifestations of systemic lupus erythematosus related to anticardiolipin antibodies. Rheumatol Int 24 (2004) 177-181
100. Ikura Y., Matsuo T., Ogami M., et al. Cytomegalovirus associated pancreatitis in a patient with systemic lupus erythematosus. J Rheumatol 27 (2000) 2715-2717
101. Eberhard B.A., Laxer R.M., Eddy A.A., et al. Presence of thyroid abnormalities in children with systemic lupus erythematosus. J Pediatr 119 (1991) 277-279
102. Katsifis G.E., and Tzioufas A.G. Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide. Lupus 13 (2004) 673-678
103. Flanc R.S., Roberts M.A., Strippoli G.F., et al. Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis 43 2 (2004) 197-208 [Abstract Full Text Full-Text PDF (235 KB)]
104. Ravelli A., Caporali R., Di Fuccia G., et al. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 148 (1994) 398-402